"Centre de traitement de pointe du cancer en Sarthe. Composé d'un service de radiothérapie, d'un service de médecine nucléaire (scintigraphie) et d'une unité de recherche clinique. Le centre propose des consultations d'oncologie, d'hématologie et de radiothérapie."

During the past decade, Clinique Victor Hugo - Centre Jean Bernard conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Victor Hugo - Centre Jean Bernard" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 3 trials, followed by "Daiichi Sankyo, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Calithera Biosciences, Inc" with 1 trials sponsored and "Incyte Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Victor Hugo - Centre Jean Bernard" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Victor Hugo - Centre Jean Bernard" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials), "Clear-cell Metastatic Renal Cell Carcinoma" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Clinique Victor Hugo - Centre Jean Bernard" in a lesser frequency.

Most popular intervention types in "Clinique Victor Hugo - Centre Jean Bernard" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (3 trials), "Capecitabine" (3 trials), "Cyclophosphamide" (2 trials), "Gemcitabine" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Victor Hugo - Centre Jean Bernard" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Victor Hugo - Centre Jean Bernard". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clinique Victor Hugo - Centre Jean Bernard, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Victor Hugo - Centre Jean Bernard, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".